A. Magill

Publications109
h-index42
Citations6,337
Highly Influential Citations263
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Berman
  • 158 Publications, 8,861 Citations
  • K. Kain
  • 414 Publications, 15,059 Citations
  • J. K. Baird
  • 245 Publications, 12,884 Citations
  • S. Sundar
  • 586 Publications, 24,624 Citations
  • Publications
  • Influence
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum
Widespread use of antimalarial agents can profoundly influence the evolution of the human malaria parasite Plasmodium falciparum. Recent selective sweeps for drug-resistant genotypes may have… Expand
  • 687
  • 64
  • PDF
Update on Rapid Diagnostic Testing for Malaria
SUMMARY To help mitigate the expanding global impact of malaria, with its associated increasing drug resistance, implementation of prompt and accurate diagnosis is needed. Malaria is diagnosed… Expand
  • 452
  • 30
  • PDF
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).
It is important to realize that leishmaniasis guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular… Expand
  • 159
  • 20
  • PDF
Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.
Primaquine phosphate has been used for preventing relapse of Plasmodium vivax and P. ovale malaria since the early 1950s, based on its ability to kill latent (hypnozoite) and developing liver stages… Expand
  • 290
  • 11
  • PDF
The epidemiology of malaria in an epidemic area of the Peruvian Amazon.
A longitudinal study of malariometric indicators and their association with potential risk factors was conducted during August 1997-July 1998 at Padre Cocha, a village of 1,400 residents in the… Expand
  • 83
  • 9
  • PDF
Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.
Treatment options for cutaneous leishmaniasis in the United States are problematic because the available products are either investigational, toxic, and/or of questionable effectiveness. A… Expand
  • 113
  • 7
  • PDF
Reducing the burden of childhood malaria in Africa: the role of improved
Malaria kills > 1 million children aged < 5 years in sub-Saharan Africa annually. Current control efforts are hampered by increasing drug resistance, unreliable diagnostics, widespread overtreatment… Expand
  • 114
  • 7
  • PDF
Averting a malaria disaster: will insecticide resistance derail malaria control?
World Malaria Day 2015 highlighted the progress made in the development of new methods of prevention (vaccines and insecticides) and treatment (single dose drugs) of the disease. However, increasing… Expand
  • 223
  • 6
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
BACKGROUND There is a need for a simple and efficacious treatment for cutaneous leishmaniasis with an acceptable side-effect profile. METHODS We conducted a randomized, vehicle-controlled phase 3… Expand
  • 164
  • 6
  • PDF
Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
Doxycycline, a synthetically derived tetracycline, is a partially efficacious causal prophylactic (liver stage of Plasmodium) drug and a slow acting blood schizontocidal agent highly effective for… Expand
  • 134
  • 6
  • PDF